What is the estimated percentage of patients with end-stage renal disease (ESRD) who develop central vein stenosis and what are the common causes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Central Vein Stenosis in ESRD: Prevalence and Causes

Central vein stenosis occurs in approximately 4-40% of patients with end-stage renal disease, with the primary cause being prior central venous catheterization, particularly subclavian vein access. 1, 2

Prevalence Estimates

The reported prevalence of central vein stenosis varies significantly depending on the population studied and detection methods:

  • Overall ESRD population: Approximately 4.3% develop symptomatic central vein stenosis during their dialysis course 2
  • Patients with prior catheter use: 6.8% develop central vein stenosis, at a rate of 2.2 per 100 patient-years 2
  • Patients with prior subclavian catheterization: 34% demonstrate >50% central vein stenosis on venography 3
  • Prevalent hemodialysis patients: Up to 40% may have central vein stenosis 1
  • Patients with cardiac devices: 64% develop stenosis after pacemaker or defibrillator placement 1

The wide range reflects that many cases remain asymptomatic and undetected unless specifically evaluated with venography. 4, 5

Primary Causes of Central Vein Stenosis

Central Venous Catheters (Most Common)

Indwelling central venous catheters account for 79% of central vein stenosis cases in ESRD patients. 6 The mechanism involves catheter-induced trauma, inflammation, microthrombi formation, intimal hyperplasia, and subsequent fibrotic response. 4

Subclavian vein catheterization carries the highest risk, with 42% of subclavian veins developing stenosis after catheter insertion. 1 This route should be strictly avoided in ESRD patients as it can permanently preclude use of the entire ipsilateral arm for future arteriovenous access. 7

Internal jugular catheters pose lower risk but still contribute to central vein stenosis, particularly with repeated insertions or prolonged duration. 7

Risk Factors by Catheter Characteristics

  • Number of previous catheters: Each additional catheter increases risk 2.2-fold (95% CI: 1.6-2.9) 2
  • Catheter duration: Longer cumulative catheter time independently increases stenosis risk 2
  • Catheter size: Larger diameter catheters (increasingly common in modern practice) likely contribute to higher stenosis rates 5

Peripherally Inserted Central Catheters (PICCs)

PICCs cause central vein stenosis in approximately 7% of cases, though this likely underestimates true incidence. 1 One study found 71.9% thrombosis rate (partial or complete vessel obliteration) at 28 days post-PICC insertion. 1 PICCs should be avoided in ESRD patients due to risk of central vein propagation and loss of future access sites. 7

Cardiac Implantable Devices

Pacemakers and implantable cardioverter-defibrillators cause central vein stenosis in 64% of ESRD patients, representing a 3.9-fold increased risk (95% CI: 1.7-8.9). 1, 2 The transvenous leads create chronic endothelial injury and thrombosis. 1

Other Contributing Factors

  • Upper extremity deep venous thrombosis: Prior DVT increases stenosis risk through residual venous damage 6
  • Younger age: Each decade of younger age at dialysis initiation increases risk 1.4-fold (RR 0.7 per decade older; 95% CI: 0.6-0.8) 2
  • Multiple catheter insertions: 14-fold increased risk of upper extremity DVT with any central venous catheter use 1

Clinical Implications

Central vein stenosis represents a serious complication that may prohibit successful arteriovenous access creation, maturation, or use. 1 While it compromises future access options and requires repeated interventions, it does not independently affect survival (median 5.1 vs 5.2 years in matched controls; P=0.54). 2

Critical prevention strategy: Avoid subclavian vein catheterization entirely in ESRD patients; use internal jugular or femoral access when temporary catheterization is necessary. 7, 3 Venography should be performed before arteriovenous fistula creation in any patient with prior central vein catheterization history. 3

The incidence of central vein stenosis is rising due to increasingly liberal use of central catheters, PICCs, and cardiac devices, making vein preservation strategies essential for this population. 4, 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Central Venous Stenosis, Access Outcome and Survival in Patients undergoing Maintenance Hemodialysis.

Clinical journal of the American Society of Nephrology : CJASN, 2019

Research

Central vein stenosis in patients with prior subclavian vein catheterization for maintenance dialysis.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 1997

Research

Central vein stenosis: current concepts.

Advances in chronic kidney disease, 2009

Guideline

Vascular Access Guidelines for Advanced Kidney Disease Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.